363 related articles for article (PubMed ID: 18760873)
1. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
2. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study.
Bar-Oz B; Weber-Schoendorfer C; Berlin M; Clementi M; Di Gianantonio E; de Vries L; De Santis M; Merlob P; Stahl B; Eleftheriou G; Maňáková E; Hubičková-Heringová L; Youngster I; Berkovitch M
Drug Saf; 2012 Jul; 35(7):589-98. PubMed ID: 22702640
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome following exposure to permethrin and use of teratogen information.
Kennedy D; Hurst V; Konradsdottir E; Einarson A
Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
[TBL] [Abstract][Full Text] [Related]
4. A prospective controlled multicentre study of clarithromycin in pregnancy.
Einarson A; Phillips E; Mawji F; D'Alimonte D; Schick B; Addis A; Mastroiacova P; Mazzone T; Matsui D; Koren G
Am J Perinatol; 1998; 15(9):523-5. PubMed ID: 9890248
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
8. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
[TBL] [Abstract][Full Text] [Related]
9. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study.
Berkovitch M; Diav-Citrin O; Greenberg R; Cohen M; Bulkowstein M; Shechtman S; Bortnik O; Arnon J; Ornoy A
Br J Clin Pharmacol; 2004 Sep; 58(3):298-302. PubMed ID: 15327589
[TBL] [Abstract][Full Text] [Related]
10. Fetal outcome following roxithromycin exposure in early pregnancy.
Chun JY; Han JY; Ahn HK; Choi JS; Koong MK; Nava-Ocampo AA; Koren G
J Matern Fetal Neonatal Med; 2006 Mar; 19(3):189-92. PubMed ID: 16690513
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
12. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
13. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
[TBL] [Abstract][Full Text] [Related]
14. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
15. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
Diav-Citrin O; Okotore B; Lucarelli K; Koren G
Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcome following in utero exposure to bisphosphonates.
Levy S; Fayez I; Taguchi N; Han JY; Aiello J; Matsui D; Moretti M; Koren G; Ito S
Bone; 2009 Mar; 44(3):428-30. PubMed ID: 19059370
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
[TBL] [Abstract][Full Text] [Related]
19. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis.
Seto A; Einarson T; Koren G
Am J Perinatol; 1997 Mar; 14(3):119-24. PubMed ID: 9259911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
